Cover Image

Antimelanoma differentiation-associated gene 5 dermatomyositis associated with acute encephalopathy

Saved in:

Bibliographic Details
Main Authors:	Morgan Nguyen, BA (Author), Jacob Groenendyk, MD (Author), Danielle Steker, MD (Author), Parul Kathuria Goyal, MD (Author), Cuong V. Nguyen, MD (Author)
Format:	Book
Published:	Elsevier, 2021-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Refractory antimelanoma differentiation-associated gene 5 antibody negative ulcerative dermatomyositis responsive to mycophenolate mofetil
by: Sumeyye Ozer, MD, et al.
Published: (2024)

Serum progranulin level is a novel tool for monitoring disease activity of dermatomyositis with antimelanoma differentiation‐associated protein 5 antibodies
by: Asami Fujii, et al.
Published: (2021)

Rapidly progressive melanoma differentiation-associated protein 5-positive amyopathic dermatomyositis in an HIV-positive patient
by: Ashutosh Sharma, BSc, et al.
Published: (2017)

Dermatomyositis associated with hyponatremia and anasarca
by: Madison Grinnell, BA, et al.
Published: (2021)

COVID-19 vaccine-associated dermatomyositis
by: Marlyn Wu, DO, et al.
Published: (2022)

Dermatomyositis associated with an adrenal adenoma
by: Sherif A. Eldirany, BS, et al.
Published: (2021)

Erythromelalgia associated with dermatomyositis: A case series
by: Madison Grinnell, BA, et al.
Published: (2021)

Relapse or recall? Docetaxel-associated re-emergence of paraneoplastic dermatomyositis
by: Drew Kuraitis, MD, PhD, et al.
Published: (2024)

Pregnancy associated anti-TIF1 dermatomyositis responsive to intravenous immunoglobulin
by: Jason Kieffer, MD, et al.
Published: (2024)

Refractory dermatomyositis responsive to anifrolumab
by: Phillip S. Ang, BA, et al.
Published: (2024)

Anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis complicated with macrophage activation syndrome
by: Yukang Ding, et al.
Published: (2022)

Prevalence and reactivity of anti-melanoma differentiation-associated gene 5 (anti-MDA-5) autoantibody in Brazilian patients with dermatomyositis
by: Isabela Bruna Pires Borges, et al.
Published: (2018)

KSHV/HHV-8 associated lymph node based lymphomas in HIV seronegative subjects. Case report and review of the literature
by: Quyen Nguyen, MD, et al.
Published: (2016)

The Effects of Mesenchymal Stem Cells on Antimelanoma Immunity Depend on the Timing of Their Administration
by: Dragana Miloradovic, et al.
Published: (2020)

Distinct purpuric lesions in patients with dermatomyositis
by: Sung Kyung Cho, BA, et al.
Published: (2021)

Palmar and lateral digital papules as a distinct feature of fatal anti-melanoma differentiation-associated gene 5 dermatomyositis
by: Tzong-Yun Ger, et al.
Published: (2020)

Overlap of Psoriatic Arthritis and Dermatomyositis
by: Christopher Schreiber MD, et al.
Published: (2021)

Overlap of dermatomyositis and cutaneous lupus erythematosus: A case series
by: Rachita Pandya, BA, et al.
Published: (2023)

Efficacy of topical ruxolitinib for cutaneous dermatomyositis
by: Aviya Lanis, MD, et al.
Published: (2024)

Anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis in a patient with silicone breast implants
by: Reimi Okubo, et al.
Published: (2024)

Blastic plasmacytoid dendritic cell neoplasm mimicking dermatomyositis
by: Christopher J. Fay, BA, et al.
Published: (2023)

Favorable Response to Adjuvant Tofacitinib in a Case of Anti-Melanoma Differentiation-Associated Gene-5 Antibody Positive Clinically Amyopathic Dermatomyositis
by: Nayankumar H. Patel, et al.
Published: (2024)

Liver Involvement is Associated with Higher Risk of Rapidly Progressive Interstitial Lung Disease and Mortality in Anti-Melanoma Differentiation-Associated Gene 5 Antibody- Positive Dermatomyositis
by: Yang X, et al.
Published: (2024)

Anti-MDA-5 Dermatomyositis With Development of Drug-Mediated Necrolytic Skin Lesions
by: Robert A. Case MD, et al.
Published: (2020)

Recurrence of juvenile dermatomyositis 8 years after remission
by: Ken Muramatsu, MD, et al.
Published: (2017)

Getting to the bottom of it: Ulcerating gluteal plaques in dermatomyositis
by: Brittany E. Yee, MD, et al.
Published: (2020)

Anti-MDA5 antibody-positive dermatomyositis presenting as unilateral eyelid edema
by: Lauren Chen, MS, et al.
Published: (2020)

Exploring Dermatomyositis through an Interdisciplinary Lens: Pearls from Dermatology and Rheumatology
by: Bina Kassamali, BA, et al.
Published: (2021)

Dermatomyositis in a COVID-19 positive patient
by: Bao Vincent K. Ho, BS, et al.
Published: (2021)

Dermatomyositis-lupuslike syndrome overlap under treatment with etanercept for rheumatoid arthritis
by: Anna Lyakhovitsky, MD, et al.
Published: (2020)

Multiple myositis-specific autoantibodies in dermatomyositis: 2 cases and review of the literature
by: Neha Narayan, BA, et al.
Published: (2022)

Prominent dyspigmentation in a patient with dermatomyositis and TIF1-γ autoantibodies
by: Daniel Gutierrez, MD, et al.
Published: (2022)

Importance of collaboration of dermatology and rheumatology to advance the field for lupus and dermatomyositis
by: Victoria P. Werth, MD, et al.
Published: (2021)

Assessment and management of the heightened risk for atherosclerotic cardiovascular events in patients with lupus erythematosus or dermatomyositis
by: Emily Keyes, BA, et al.
Published: (2021)

A Rare Case of Anti-TIF-1γ Antibody Positive Dermatomyositis in Adulthood
by: Upasana Agrawal MD, et al.
Published: (2024)

Case of recalcitrant amyopathic dermatomyositis treated with upadacitinib
by: Albert E. Zhou, MD, PhD, et al.
Published: (2024)

Panniculitis associated with amyopathic dermatomyositis
by: Paula de Oliveira Azevedo, et al.
Published: (2018)

Gastroparesis associated with Juvenile Dermatomyositis
by: Martin N, et al.
Published: (2008)

Paraneoplastic dermatomyositis in association with poorly differentiated esophageal carcinoma - A rare association and a brief review of literature
by: Swaroopa Subhash, et al.
Published: (2020)

Postherpes zoster programmed death-1 inhibitor−associated zosteriform granulomatous reactions
by: Simran A. Chadha, BS, et al.
Published: (2020)